In consonance with these data, it has been demonstrated the increase in the soluble form of Cd163 in cerebrospinal fluid (CSF) in late Parkinson’s disease (PD) cases that was associated with cognitive decline condition [37]. This evidence concerns the gene CD163 and Parkinson disease.